Optimal treatment intensification for glycaemic control in patients with type 2 diabetes on two oral agents: real world comparison of GLP-1, OADs and insulin

被引：0
|
作者：
Desouza, C. [1 ]
Kirk, A. Ross [2 ]
Mangla, K. Kant [3 ]
Wolden, M. Lyng [2 ]
Lingvay, I. [4 ]
机构：
[1] Univ Nebraska Med Ctr, Omaha, NE USA
[2] Novo Nordisk AS, Soborg, Denmark
[3] Novo Nordisk Serv Ctr India Pvt Ltd, Bangalore, Karnataka, India
[4] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX USA
来源：
DIABETOLOGIA | 2020年 / 63卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
596
引用
收藏
页码：S286 / S287
页数：2
相关论文
共 50 条
  • [21] Real-world sex differences in type 2 diabetes patients treated with GLP-1 receptor agonists
    Piccini, Sara
    Favacchio, Giuseppe
    Morenghi, Emanuela
    Mazziotti, Gherardo
    Lania, Andrea G. A.
    Mirani, Marco
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 212
  • [22] Real world glucose and weight control in patients treated with GLP-1 receptor agonists, with addition or treatment change to insulin
    Klein, K.
    Shaunik, A.
    Paul, S.
    DIABETOLOGIA, 2015, 58 : S384 - S384
  • [23] Sustained improvement of glycaemic control by insulin treatment in patients with type 2 diabetes
    Lindström, T
    DIABETOLOGIA, 1998, 41 : A248 - A248
  • [24] Glucagonostatic Potency of GLP-1 in Patients With Type 2 Diabetes, Patients With Type 1 Diabetes, and Healthy Control Subjects
    Bagger, Jonatan, I
    Grondahl, Magnus F. G.
    Lund, Asger
    Holst, Jens J.
    Vilsboll, Tina
    Knop, Filip K.
    DIABETES, 2021, 70 (06) : 1347 - 1356
  • [25] Options for intensification of basal insulin in type 2 diabetes: Premeal insulin or short-acting GLP-1 receptor agonists?
    Darmon, P.
    Raccah, D.
    DIABETES & METABOLISM, 2015, 41 : S21 - S27
  • [26] De-intensification of basal-bolus insulin regimen after initiation of a GLP-1 RA improves glycaemic control and promotes weight loss in subjects with type 2 diabetes
    Falcetta, Pierpaolo
    Nicoli, Francesca
    Citro, Fabrizia
    Ciccarone, Annamaria
    Garofolo, Monia
    Del Prato, Stefano
    Bianchi, Cristina
    ACTA DIABETOLOGICA, 2023, 60 (01) : 53 - 60
  • [27] De-intensification of basal-bolus insulin regimen after initiation of a GLP-1 RA improves glycaemic control and promotes weight loss in subjects with type 2 diabetes
    Pierpaolo Falcetta
    Francesca Nicolì
    Fabrizia Citro
    Annamaria Ciccarone
    Monia Garofolo
    Stefano Del Prato
    Cristina Bianchi
    Acta Diabetologica, 2023, 60 : 53 - 60
  • [28] Comparison of glycaemic control in patients with Type 2 diabetes on basal insulin and fixed combination oral antidiabetic treatment: results of a pilot study
    De Mattia, G.
    Laurenti, O.
    Moretti, A.
    ACTA DIABETOLOGICA, 2009, 46 (01) : 67 - 73
  • [29] Comparison of glycaemic control in patients with Type 2 diabetes on basal insulin and fixed combination oral antidiabetic treatment: results of a pilot study
    G. De Mattia
    O. Laurenti
    A. Moretti
    Acta Diabetologica, 2009, 46
  • [30] A comparison of currently available GLP-1 receptor agonists for the treatment of type 2 diabetes
    Montanya, Eduard
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (10) : 1451 - 1467
12345